Mycogen Plant Science Inc v Monsanto Australia Ltd
[2001] FCA 143
At a glance
Source factsCourt
Federal Court of Australia
Decision date
2001-02-26
Before
Kenny J
Source
Original judgment source is linked above.
Judgment (10 paragraphs)
the applicant's opposition 13 The applicant opposes the respondents' applications upon a number of bases. First, the information sought is not, it submits, properly a matter for particulars. It says that what the respondents are seeking is a paraphrase of the claim. Secondly, it submits that the provision of the information sought would not clarify the issues in dispute. It says its position might well be that there is an infringement even on some construction propounded by the respondents (or the Court). Further, the applicant submits that the difficulties foreshadowed by the respondents with respect to experimental proofs may properly be met by an application for directions under O 58, r 31 of the Federal Court Rules. 14 For present purposes, I accept that it would not be appropriate to require the applicant to proffer a paraphrase of claim 1. I accept that there may be legitimate difficulties in formulating a specific interpretation for each of the expressions said by the respondents to require elucidation. The process of interpretation which the respondents' application invites may be inappropriate because the claim is to be read as a whole and to be construed according to its terms upon ordinary principles: see Decor Corporation Pty Ltd v Dart Industries Inc (1988) 13 IPR 385 at 400 per Sheppard J. I accept, as the applicant submits, that an "overly minute dissection of the claim … may end up producing a result which fits [the applicant] into a strait jacket" (tpt 47), and that this may be unfair. 15 At least for someone without a specialised knowledge of bacterial molecular biology, the subject matter of the Second Patent is far from straightforward. This may well be a case, as the applicant submits, in which the language of the claims is to be construed as a whole and in light of the technology with which it is concerned. Leaving aside the words "comprising" and "comprises", it may be that many of the uncertainties said by the respondents to infect claim 1 would fade away when this technology is properly explained. Further, this may be a case in which the meaning of technical words used in the claim may be qualified or defined by what is said in the body of the specification, and the evidence of persons skilled in the art may well prove significant. 16 For the reasons stated above, I reject the respondents' submission that the applicant should on this application be required to proffer its preferred construction of each of the expressions identified by the respondents as giving rise to difficulties. 17 If these were the only considerations affecting the disposition of the respondents' applications, I should not at this stage be disposed to direct further and better particulars, although I might well entertain a further application for a statement of the applicant's case pursuant to O 12, r 5(1)(b) at a later date (e.g. after the applicant's affidavit material had been filed and served) if that proved appropriate. 18 There is, however, another consideration to which I now turn. It was a part of the applicant's submissions that the only real issue in the proceeding is the respondents' gene sequence. The applicant concedes that its case of infringement depends, at this stage at least, on a sequence or sequences appearing in published data. It is not unreasonable, it seems to me, to assume that the applicant is capable of stating with greater particularity than it has hitherto done what it is about the gene sequence of the respondents' products which it says infringes claim 1 of the Second Patent. Indeed, the applicant accepts that it could be appropriate to direct that it provide a statement of the nature of the case it makes about the respondents' gene sequence. It submits, however, that any such direction should await the completion of discovery and inspection, because it would only be then that all the offending sequences would be known by it. This would, so the applicant submits, be a more efficient course, since it would avoid any need to prepare a statement while carrying out the discovery process or to amend the statement upon completion of inspection. 19 I am not persuaded that a possible need to amend means that it would be more efficient to postpone the making of any statement until the completion of the discovery process. If the applicant has legitimate concerns that a statement of its case would improperly limit the discovery to be made by the respondents, those concerns are answered in large part by the fact that the respondents have already disclosed the seeds for transgenic ingard cotton that have been made in Australia. The sequences for these seeds would, so the first respondent accepts, properly be the subject of discovery and inspection. Further, as the first respondent notes, there is a large body of material available to the applicant by virtue of its own and the first respondent's involvement in infringement proceedings in the United States of America. If, as a result of discovery, the applicant were to be made aware of other sequences infringing claim 1, then it could amend the statement of its case, providing it did so in a timely way. The case management practices in this Court contemplate that the nature of any case be identified clearly and precisely as early in a proceeding as is reasonably practicable: cf Caterpillar Inc v Sun Forward Pty Ltd (1996) 36 IPR 411 at 413 citing Lenijamar Pty Ltd v AGC (Advances) Ltd (1990) 27 FCR 388 at 394-5. Of course, I accept, as the second respondent observes, that it would be wrong to construe a claim by reference to an alleged infringement. This is not what is intended by granting part only of the respondents' application. The object of the orders proposed below is to identify as far as reasonably practicable at this stage the cases the parties are to meet at trial in order that their pre-trial preparation might be efficiently performed. 20 The applicant disputes that any statement of its case should include a statement of what the first respondent's counsel called "reference points" on the basis that this is not the language of claim 1. It is plain enough, however, what counsel intends by the expression "references points". They mean the thing, value, standard etc used as a basis for comparative measurement. For its statement to be useful, the applicant must provide some account (whether by words or diagram) of what it says is the basis for measuring the respondents' gene sequence against claim 1. For the reasons stated, the orders I propose are: (1) within 28 days the applicant file and serve a statement of the facts relied on by it to show that when the respondents' gene sequence (or sequences) is (or are) compared with claim 1 of the Second Patent, infringement is shown, including an account of the basis for comparative measurement and how that measurement is made or calculated. (2) within 28 days of the receipt of the applicant's statement, each of the respondents file and serve a statement of the facts relied on by it to show that the said gene sequence (or sequences) do not infringe claim 1 of the Second Patent, including an account of the basis for comparative measurement and how that measurement is made or calculated.